BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 18, 2010
View Archived Issues
Roche Steps Back from RNA Interference, Cuts 6% of Staff
As part of a cost-cutting corporate restructuring, Roche AG plans to discontinue its preclinical research in the area of RNA interference (RNAi) at sites in Kulmbach, Germany; Madison, Wisc.; and Nutley, N.J. (BioWorld Today)
Read More
Avanir Raising $88M Post-Nuedexta Approval
Read More
From 'FAB' to Flush: Sutro Adding $36.5M in Series C
Read More
Investors Hammer Resverlogix Over Cholesterol Drug Data
Read More
Forma Will Get $20M from Eisai in Drug Discovery Deal
Read More
Clinic Roundup
Read More
Stock Movers
Read More
Other News To Note
Read More